Overview
Makoto Inada practices in Hongo, Japan. Mr. Inada is rated as an Experienced expert by MediFind in the treatment of Streptococcal Group A Infection. His top areas of expertise are Toxic Shock Syndrome, Cerebral Hypoxia, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Streptococcal Group A Infection.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisMr. Inada isExperienced. Learn about Agranulocytosis.
- Cerebral HypoxiaMr. Inada isExperienced. Learn about Cerebral Hypoxia.
- COVID-19Mr. Inada isExperienced. Learn about COVID-19.
- Diabetic RetinopathyMr. Inada isExperienced. Learn about Diabetic Retinopathy.
- EndocarditisMr. Inada isExperienced. Learn about Endocarditis.
- Increased Intracranial PressureMr. Inada isExperienced. Learn about Increased Intracranial Pressure.